# A Single-arm Exploratory Study of Neoadjuvant Therapy

> **NCT05527808** · NA · UNKNOWN · sponsor: **Jun Liu** · enrollment: 28 (estimated)

## Conditions studied

- Lung Adenocarcinoma

## Interventions

- **DRUG:** Tislelizumab
- **DRUG:** pemetrexed
- **DRUG:** cis-platemum
- **DRUG:** or carboplatin

## Key facts

- **NCT ID:** NCT05527808
- **Lead sponsor:** Jun Liu
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-08-01
- **Primary completion:** 2025-06-30
- **Final completion:** 2025-12-30
- **Target enrollment:** 28 (ESTIMATED)
- **Last updated:** 2023-06-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05527808

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05527808, "A Single-arm Exploratory Study of Neoadjuvant Therapy". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05527808. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*